Aptevo Therapeutics (APVO) CMO converts RSUs; 156 shares withheld for taxes
Rhea-AI Filing Summary
Aptevo Therapeutics Inc. officer Dirk Huebner (SVP, CMO) reported the vesting and settlement of 638 Restricted Stock Units (RSUs) into 638 shares of common stock on August 6, 2026. The RSUs, originally granted on August 6, 2025, converted to common stock on a one-for-one basis. In a related transaction, 156 shares of common stock were withheld by the issuer at $4.07 per share to satisfy tax withholding obligations on the RSU vesting.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 482 shares
Net Buy
3 txns
Insider
Huebner Dirk
Role
SVP, CMO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit F1, F3 | 638 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 638 | -- | -- |
| Tax Withholding | Common Stock F2 | 156 | $4.07 | $634.92 |
Holdings After Transaction:
Restricted Stock Unit — 0 shares (Direct);
Common Stock — 482 shares (Direct)
Footnotes (3)
- F1. Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- F2. Represents shares withheld by Issuer to satisfy tax withholding obligations on the vesting of RSUs.
- F3. On August 6, 2025, the reporting person was granted 11,500 (638 post-split) RSUs, vesting on the first anniversary of the date of grant.
Key Figures
RSUs converted: 638 RSUs
Common shares issued from RSUs: 638 shares
Shares withheld for taxes: 156 shares at $4.07 per share
+1 more
4 metrics
RSUs converted
638 RSUs
Restricted Stock Units converting into common stock on August 6, 2026
Common shares issued from RSUs
638 shares
Shares of common stock received upon RSU conversion
Shares withheld for taxes
156 shares at $4.07 per share
Common stock withheld to satisfy tax withholding obligations on RSU vesting
Original RSU grant size (pre-split)
11,500 RSUs (638 post-split)
Grant to Dirk Huebner on August 6, 2025 vesting on first anniversary
Key Terms
Restricted Stock Unit, tax withholding obligations, par value
3 terms
Restricted Stock Unit financial
"Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
tax withholding obligations financial
"Represents shares withheld by Issuer to satisfy tax withholding obligations on the vesting"
par value financial
"common stock, $0.001 par value per share, of the Issuer on a one-for-one basis"
Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did APVO officer Dirk Huebner report on August 6, 2026?
Dirk Huebner reported the vesting and settlement of 638 RSUs into 638 shares of Aptevo Therapeutics (APVO) common stock, reflecting an exercise/conversion of previously granted equity compensation.
What equity award originally led to the reported RSU vesting at APVO?
The RSUs vesting on August 6, 2026 came from an award granted on August 6, 2025 of 11,500 RSUs (638 post-split), which were structured to vest on the first anniversary of the grant date.
Did the APVO Form 4 report an open-market buy or sell by Dirk Huebner?
No open-market buy or sell is reported. The Form 4 reflects an RSU conversion into common stock and shares withheld to cover tax obligations, rather than discretionary market purchases or sales.
What types of securities were involved in Dirk Huebner’s APVO Form 4 filing?
The filing involves Restricted Stock Units (RSUs), which converted into common stock, and a separate transaction where common shares were withheld by Aptevo Therapeutics to satisfy tax withholding obligations.